Go to
JCI Insight
Citations to this article
Bianca M. Conti-Fine, … , Monica Milani, Henry J. Kaminski
Published November 1, 2006
Citation Information: J Clin Invest. 2006;116(11):2843-2854. https://doi.org/10.1172/JCI29894.
Citation Information: J Clin Invest. 2006;116(11):2843-2854. https://doi.org/10.1172/JCI29894.
Abstract
Myasthenia gravis (MG) is an autoimmune syndrome caused by the failure of neuromuscular transmission, which results from the binding of autoantibodies to proteins involved in signaling at the neuromuscular junction (NMJ). These proteins include the nicotinic AChR or, less frequently, a muscle-specific tyrosine kinase (MuSK) involved in AChR clustering. Much is known about the mechanisms that maintain self tolerance and modulate anti-AChR Ab synthesis, AChR clustering, and AChR function as well as those that cause neuromuscular transmission failure upon Ab binding. This insight has led to the development of improved diagnostic methods and to the design of specific immunosuppressive or immunomodulatory treatments.
Authors
Bianca M. Conti-Fine, Monica Milani, Henry J. Kaminski
Total citations by year
Citation information
Citations to this article (223)
| Title and authors | Publication | Year |
|---|---|---|
|
Racial disparities in acute care utilization among individuals with myasthenia gravis
Qi C, Narayanaswami P, Anderson AE, Gelinas D, Li Y, Guptill JT, Amirthaganesan D, Ward C, Panchal R, Goyal A, Phillips G |
Frontiers in Public Health | 2025 |
|
Comprehensive Analysis of Uric Acid and Myasthenia Gravis: IGF1R as a Protective Factor and Potential Therapeutic Target
Shen Y, Pang L, Wang H, Han Q, Wan W, Luo S, Song Z, Fang Y, Chen H, Qiu Y, Tan D, Zhou M, Hong D |
CNS Neuroscience & Therapeutics | 2025 |
|
Efgartigimod Followed by Telitacicept in Adult Generalized Myasthenia Gravis: A Retrospective Case Series
Zhang Y, Fang Z, Liu Y, Wan B, Zhang Q, Qu X, Pan S, Zhang Y, Dai Y, Yang S, Li J, Zhang X |
Journal of Inflammation Research | 2025 |
|
The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?
Michailidou I, Patsiarika A, Kesidou E, Boziki MK, Parisis D, Bakirtzis C, Chroni E, Grigoriadis N |
Frontiers in Immunology | 2025 |
|
Myasthenia Gravis Presenting With Vocal Cord Paralysis As the Initial Symptom Occurring One Week Following Herpes Zoster Vaccination: A Case Report and Review of the Literature
Asada S, Odera H, Morishita K, Mori S |
Cureus | 2025 |
|
Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients
Mané-Damas M, Saxena A, Nogales-Gadea G, Stevens J, Vincken S, van Beek M, van den Hoogen NJ, Joosten EA, Willcox N, Duimel H, Maessen JG, Molenaar PC, De Baets MH, Losen M, Martinez-Martinez P |
Frontiers in Immunology | 2025 |
|
Neuromorphic chips for biomedical engineering
Wang K, Ren S, Jia Y, Yan X, Wang L, Fan Y |
Mechanobiology in Medicine | 2025 |
|
Oral bacteria induce IgA autoantibodies against a mesangial protein in IgA nephropathy model mice.
Higashiyama M, Haniuda K, Nihei Y, Kazuno S, Kikkawa M, Miura Y, Suzuki Y, Kitamura D |
Life science alliance | 2024 |
|
Autoimmune Autonomic Neuropathy: From Pathogenesis to Diagnosis.
Nakane S, Koike H, Hayashi T, Nakatsuji Y |
International journal of molecular sciences | 2024 |
|
Myasthenia Gravis: The Future is Here
Henry J. Kaminski, Patricia Sikorski, Isabel Coronel, Linda L. Kusner |
Journal of Clinical Investigation | 2024 |
|
Heterologous fibrin biopolymer as an emerging approach to peripheral nerve repair: a scoping review
Muller KS, Tibúrcio FC, Ferreira RS Junior, Barraviera B, Matheus SM |
2024 | |
|
Development of Upper Extremity Deep Vein Thrombosis in a Patient With Seronegative Myasthenia Gravis: A Case Report and Review of Literature
Cohen NE, Cook AC, Narvel R |
Cureus | 2024 |
|
Autoimmune and Non-Autoimmune Comorbidities in Myasthenic Patients of East-European Descent: A Case-Control Study.
Croitoru CG, Pavel-Tanasa M, Cuciureanu DI, Hodorog DN, Cianga P |
Journal of Clinical Medicine | 2024 |
|
IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model.
Miyake S, Serizawa K, Onishi S, Katsura Y, Baba M, Kurasawa M, Tomizawa-Shinohara H, Yorozu K, Matsumoto Y, Noguchi-Sasaki M |
Frontiers in neurology | 2024 |
|
Myasthenia gravis and pregnancy: Lessons learned from a complex a case report
Benlghazi A, Messaoudi H, Belouad M, Bouhtouri Y, Benali S, Rachid AB, El Mangoub F, Elhassani MM, Kouach J |
SAGE Open Medical Case Reports | 2024 |
|
Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities
Ma C, Liu D, Wang B, Yang Y, Zhu R |
Frontiers in pharmacology | 2024 |
|
Extended abstract: cancer and autoimmunity: survivin as a driver of sustaining autoreactive cells and its role in neoplasia
Kusner LL |
2024 | |
|
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis
Yin J, Zhao M, Xu X, Zhang M, Xu Z, Li Z, Qin X, Li Z, Zhao C, Zhou H, Ma Y, Cao W, Wang G, Lin Y, Zhang J, Zhang X, Cai H, Qian W, Wang Y, Zhang X, Liu G, Wang J, Qiu W, Min L, Li J, Deng H, Chu L, Zhang Y, Fang J |
European Journal of Neurology | 2024 |
|
FOSL1-mediated LINC01566 negatively regulates CD4(+) T-cell activation in myasthenia gravis.
Li L, Li D, Jin J, Xu F, He N, Ren Y, Wang X, Tian L, Chen B, Li X, Chen Z, Zhang L, Qiao L, Wang L, Wang J |
Journal of Neuroinflammation | 2024 |
|
Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments.
Tavakoli GM, Yazdanpanah N, Rezaei N |
Advances in rheumatology (London, England) | 2024 |
|
Weaning from mechanical ventilation during myasthenic crisis, a monocentric retrospective study.
Mazeraud A, Sivanandamoorthy S, Mancusi R, Clair B, Friedman D, Fadel F, Maxime V, Legouy C, Orlikowski D, Sharshar T, Heming N, Annane D |
Scientific reports | 2024 |
|
Patient and care partner perspectives and preferences related to myasthenia gravis treatment: A qualitative study
Yung M, Narayanaswami P, Pesa J, Choudhry Z, Jackson L, Deering KL, Sebaaly J, Richardson J, Feldman J, Peters W, Taylor M, Foss A, West B, Shea L, Geonnotti G, Govindarajan R |
Health Science Reports | 2024 |
|
Exhausted signature and regulatory network of NK cells in myasthenia gravis
Zhang Q, Han X, Bi Z, Yang M, Lin J, Li Z, Zhang M, Bu B |
Frontiers in Immunology | 2024 |
|
Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine
Iacomino N, Tarasco MC, Berni A, Ronchi J, Mantegazza R, Cavalcante P, Foti M |
Cells | 2024 |
|
Efficacy and safety of immunosuppressants and monoclonal antibodies in adults with myasthenia gravis: a systematic review and network meta-analysis
Gu J, Qiao Y, Huang R, Cong S |
Journal of Translational Medicine | 2024 |
|
Unusual Presentation of Double-seronegative Myasthenia Gravis with Positive Anti-LRP4 Antibody: Diagnostic Utility of a Videofluoroscopic Swallowing Study
Yanai K, Takahashi S, Soejima I, Oniki A, Matsuda T, Ishihara S, Higuchi O, Tomimitsu H |
Internal Medicine | 2024 |
|
Evaluation of nonmotor symptoms in myasthenia gravis patients
TEKEŞİN A, ŞİŞMAN Ç, TOPRAK UE, SAR A, AKALIN B, KOŞARGELİR G, TÜTÜNCÜ M, YİĞİT E |
Turkish Journal of Medical Sciences | 2024 |
|
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG
Dewilde S, Philips G, Paci S, Beauchamp J, Chiroli S, Quinn C, Day L, Larkin M, Palace J, Berrih-Aknin S, Claeys KG, Muppidi S, Mantegazza R, Saccà F, Meisel A, Bassez G, Murai H, Janssen M |
BMJ Open | 2023 |
|
Oculomotor fatigability with decrements of saccade and smooth pursuit for diagnosis of myasthenia gravis.
Nguyen TT, Kang JJ, Chae JH, Lee E, Kim HJ, Kim JS, Oh SY |
Journal of Neurology | 2023 |
|
Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.
Betterle C, Furmaniak J, Sabbadin C, Scaroni C, Presotto F |
Journal of Endocrinological Investigation | 2023 |
|
Intermolecular And Dynamic Investigation of The Mechanism of Action of Reldesemtiv on Fast Skeletal Muscle Troponin Complex Toward the Treatment of Impaired Muscle Function.
Issahaku AR, Ibrahim MAA, Mukelabai N, Soliman MES |
The Protein Journal | 2023 |
|
Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review.
Pinto AA, De Seze J, Jacob A, Reddel S, Yudina A, Tan K |
Therapeutic advances in neurological disorders | 2023 |
|
New diagnosis of myasthenia gravis in the third trimester - A case report.
Aitken A, Kanitkar S |
2023 | |
|
Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem.
Sharma R, Ahmed S, Campagnari J, Huff W, Lloyd L |
Pharmaceutical medicine | 2023 |
|
Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)
Berrih-Aknin S, Palace J, Meisel A, Claeys KG, Muppidi S, Saccà F, Amini F, Larkin M, Quinn C, Beauchamp J, Philips G, De Ruyck F, Ramirez J, Paci S |
BMJ Open | 2023 |
|
Global research hotspots and frontiers of myasthenia gravis from 2002 to 2021: A bibliometric study.
Yang J, Wu J, Han T, Lu H, Li F, Li L, Su S, Jiang P, Hou Z |
Medicine | 2023 |
|
Epigenome‐wide DNA methylation analysis of myasthenia gravis
Lin J, Tao L, Deng L, Zhou R, Lou S, Chen S, Chen X, Lu C, Li P, Hu B |
FEBS Open Bio | 2023 |
|
People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies.
Dewilde S, Phillips G, Paci S, De Ruyck F, Tollenaar NH, Janssen MF |
Advances in Therapy | 2023 |
|
Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota.
Weng S, Huang L, Cai B, He L, Wen S, Li J, Zhong Z, Zhang H, Huang C, Yang Y, Jiang Q, Liu F |
Chinese medicine | 2023 |
|
Development and Assessment of an Artificial Intelligence-Based Tool for Ptosis Measurement in Adult Myasthenia Gravis Patients Using Selfie Video Clips Recorded on Smartphones.
Lootus M, Beatson L, Atwood L, Bourdais T, Steyaert S, Sarabu C, Framroze Z, Dickinson H, Steels JC, Lewis E, Shah NR, Rinaldo F |
2023 | |
|
Stability monitoring of patients with myasthenia gravis using a mobile-based application
Alaei Tafti E, Ghazisaeedi M, Sarraf P |
2023 | |
|
Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
Vallés AS, Barrantes FJ |
Cells | 2023 |
|
Causal relationship between gut microbiota and myasthenia gravis: a bidirectional mendelian randomization study
Su T, Yin X, Ren J, Lang Y, Zhang W, Cui L |
Cell & Bioscience | 2023 |
|
Hip Fracture in a Patient with Overlap Syndrome - Conundrums Involved in the Management - A Case Report
Narayan MS, Sameer M, Viburajah V |
Journal of Orthopaedic Case Reports | 2023 |
|
Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysis
Chen H, Qiu Y, Yin Z, Wang Z, Tang Y, Ni H, Lu J, Chen Z, Kong Y, Wang Z |
Frontiers in immunology | 2023 |
|
Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background
Hayashi M |
Pathophysiology | 2023 |
|
Exploring the Gut Microbiome in Myasthenia Gravis
Thye AY, Law JW, Tan LT, Thurairajasingam S, Chan KG, Letchumanan V, Lee LH |
Nutrients | 2022 |
|
Post-synaptic specialization of the neuromuscular junction: junctional folds formation, function, and disorders
Zou S, Pan BX |
Cell & Bioscience | 2022 |
|
Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy
Iacomino N, Vanoli F, Frangiamore R, Ballardini M, Scandiffio L, Bortone F, Andreetta F, Baggi F, Bernasconi P, Antozzi C, Cavalcante P, Mantegazza R |
Biomedicines | 2022 |
|
Myasthenia Gravis and Myeloproliferative Neoplasms – Mere Association or Paraneoplastic Neurologic Syndrome: A Mini-Review
Sasi S, Mohamed M, P C, Yassin MA |
2022 | |
|
An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine
Sonigra KJ, Sarna K, Vaghela VP, Guthua S |
Cureus | 2022 |
|
Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States
Phillips G, Abreu C, Goyal A, Li Y, Whangbo A, Gelinas D, Brauer E, Bhattacharya S |
Frontiers in neurology | 2022 |
|
Neurological Manifestations of Myocarditis
Trifan G, Testai FD |
Current Neurology and Neuroscience Reports | 2022 |
|
“Listen to Your Immune System When It’s Calling for You”: Monitoring Autoimmune Diseases Using the iShU App
Ortet C, Vale Costa L |
Sensors (Basel, Switzerland) | 2022 |
|
LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis
Liu L, Zhang H, Lu X, Li L, Wang T, Li S, Wang X, Xu S, Li L, Li Q, Yi T, Wu T, Chen Z, Gao H, Wang J, Wang L |
Frontiers in neurology | 2022 |
|
Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy
Wang Y, Yan C, Su C, Wang Y, Luo S, Lu J, Zhao C, Zhao G, Xi J |
Frontiers in neurology | 2022 |
|
Utilization of MG‐ADL in myasthenia gravis clinical research and care
Muppidi S, Silvestri NJ, Tan R, Riggs K, Leighton T, Phillips GA |
Muscle & Nerve | 2022 |
|
Ectopic germinal centers in the thymus accurately predict prognosis of myasthenia gravis after thymectomy
Sarkkinen J, Dunkel J, Tuulasvaara A, Huuskonen A, Atula S, Kekäläinen E, Laakso SM |
Modern Pathology | 2022 |
|
Pathophysiological basis in the management of myasthenia gravis: a mini review.
Binu A, Kumar SS, Padma UD, Madhu K |
InflammoPharmacology | 2022 |
|
Effects of intravascular photobiomodulation on motor deficits and brain perfusion images in intractable myasthenia gravis: A case report
Lan CH, Wu YC, Chiang CC, Chang ST |
World journal of clinical cases | 2022 |
|
Study on the Potential Mechanism of Semen Strychni against Myasthenia Gravis Based on Network Pharmacology and Molecular Docking with Experimental Verification
Fang P, Yu C, Liu J, Deng G, Zhang M |
Evidence-based complementary and alternative medicine : eCAM | 2022 |
|
Validation of myasthenia gravis activity of daily living questionnaire: Persian version
Faghani S, Okhvat AA, Karimi N, Moassefi M, Maroufi SF, Nafissi S, Fatehi F |
2022 | |
|
COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.
Peric S, Rankovic M, Bozovic I, Radosavljevic V, Marjanovic I, Basta I, Lavrnic D |
Acta Neurologica Belgica | 2022 |
|
Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study.
Jackson K, Parthan A, Lauher-Charest M, Broderick L, Law N, Barnett C |
Neurology and Therapy | 2022 |
|
A novel murine model of autoimmune dysautonomia by α3 nicotinic acetylcholine receptor immunization
Yamakawa M, Nakane S, Ihara E, Tawara N, Ikeda H, Igarashi Y, Komohara Y, Takamatsu K, Ikeda T, Tomita Y, Murai S, Ando Y, Mukaino A, Ogawa Y, Ueda M |
Frontiers in neuroscience | 2022 |
|
Myasthenia gravis in clinical practice
Estephan ED, Baima JP, Zambon AA |
Arquivos de Neuro-Psiquiatria | 2022 |
|
Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system.
Schmidt CQ, Smith RJH |
Immunological Reviews | 2022 |
|
The emerging role of complement in neuromuscular disorders
JD Lee, TM Woodruff |
Seminars in Immunopathology | 2021 |
|
Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis
Z Yu, M Zhang, H Jing, P Chen, R Cao, J Pan, B Luo, Y Yu, BM Quarles, W Xiong, MH Rivner, L Mei |
Neurology | 2021 |
|
A systematic review of myasthenia gravis complicated with myocarditis
W Cheng, T Sun, C Liu, Z Zhou, J Duan, Y Zhao, M Yang, P Chen |
Brain and Behavior | 2021 |
|
Oral function in patients with myasthenia gravis
AO Donskov, A Shimada, L Vinge, P Svensson, H Andersen |
PeerJ | 2021 |
|
Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)
S Berrih-Aknin, KG Claeys, N Law, R Mantegazza, H Murai, F Saccà, S Dewilde, MF Janssen, E Bagshaw, H Kousoulakou, M Larkin, J Beauchamp, T Leighton, S Paci |
BMJ Open | 2021 |
|
Upregulation of circ‐FBL promotes myogenic proliferation in myasthenia gravis by regulation of miR‐133/PAX7
X Lai, Z Bi, X Yang, R Hu, L Wang, M Jin, L Li, B Bu |
Cell Biology International | 2021 |
|
Epidemiology of Ocular Manifestations in Autoimmune Disease
K Glover, D Mishra, TR Singh |
Frontiers in immunology | 2021 |
|
Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease
Cleanthous S, Mork AC, Regnault A, Cano S, Kaminski HJ, Morel T |
Orphanet Journal of Rare Diseases | 2021 |
|
Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis
Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, Shohaimi S, Mohammadi M |
Journal of Translational Medicine | 2021 |
|
Computed tomography radiomics for the prediction of thymic epithelial tumor histology, TNM stage and myasthenia gravis
Blüthgen C, Patella M, Euler A, Baessler B, Martini K, von Spiczak J, Schneiter D, Opitz I, Frauenfelder T |
PloS one | 2021 |
|
Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
Li S, Wang X, Wang T, Zhang H, Lu X, Liu L, Li L, Bo C, Kong X, Xu S, Ning S, Wang J, Wang L |
Journal of Translational Medicine | 2021 |
|
A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics
Smith VM, Nguyen H, Rumsey JW, Long CJ, Shuler ML, Hickman JJ |
Frontiers in Cell and Developmental Biology | 2021 |
|
Hemisensory loss in myasthenia gravis
Marshall B, Sharma U, Benes-Lima L, Rossi FH |
BMJ case reports | 2021 |
|
Complement Inhibitor Therapy for Myasthenia Gravis
K Albazli, HJ Kaminski, JF Howard |
Frontiers in immunology | 2020 |
|
Impairment Mechanisms and Intervention Approaches for Aged Human Neuromuscular Junctions
Y Badawi, H Nishimune |
Frontiers in molecular neuroscience | 2020 |
|
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis
Y Li, JT Guptill, MA Russo, JF Howard, JM Massey, VC Juel, LD Hobson-Webb, D Emmett, M Chopra, S Raja, W Liu, JS Yi |
Journal of Neuroimmunology | 2020 |
|
The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model
X Zhang, M Ciesielski, RA Fenstermaker, HJ Kaminski, LL Kusner |
Journal of immunology (Baltimore, Md. : 1950) | 2020 |
|
Myasthenia gravis therapy with individualized homeopathy: A case report
V Văcăraș, C Nistor, I Rahovan, C Văcăraş, G Vithoulkas |
Clinical Case Reports | 2020 |
|
Monoclonal Antibody-Based Therapies for Myasthenia Gravis
S Alabbad, M AlGaeed, P Sikorski, HJ Kaminski |
BioDrugs | 2020 |
|
Roles of cytokines and T cells in the pathogenesis of myasthenia gravis
A Uzawa, S Kuwabara, S Suzuki, T Imai, H Murai, Y Ozawa, M Yasuda, Y Nagane, K Utsugisawa |
Clinical & Experimental Immunology | 2020 |
|
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
JF Howard, RJ Nowak, GI Wolfe, ML Freimer, TH Vu, JL Hinton, M Benatar, PW Duda, JE MacDougall, R Farzaneh-Far, HJ Kaminski, R Barohn, M Dimachkie, M Pasnoor, C Farmakidis, T Liu, S Colgan, MG Benatar, T Bertorini, R Pillai, R Henegar, M Bromberg, S Gibson, T Janecki, M Freimer, B Elsheikh, P Matisak, A Genge, A Guidon, W David, AA Habib, V Mathew, T Mozaffar, JL Hinton, W Hewitt, D Barnett, P Sullivan, D Ho, JF Howard, RE Traub, M Chopra, HJ Kaminski, R Aly, E Bayat, M Abu-Rub, S Khan, D Lange, S Holzberg, B Khatri, E Lindman, T Olapo, LM Sershon, RP Lisak, E Bernitsas, K Jia, R Malik, TD Lewis-Collins, M Nicolle, RJ Nowak, A Sharma, B Roy, J Nye, M Pulley, A Berger, Y Shabbir, A Sachdev, K Patterson, Z Siddiqi, M Sivak, J Bratton, G Small, A Kohli, M Fetter, T Vu, L Lam, B Harvey, GI Wolfe, N Silvestri, K Patrick, K Zakalik, PW Duda, J MacDougall, R Farzaneh-Far, A Pontius, M Hoarty |
JAMA NEUROL | 2020 |
|
Maximising the potential of neuroimmunology
LJ Caldwell, S Subramaniam, G MacKenzie, DK Shah |
Brain, Behavior, and Immunity | 2020 |
|
Structure-Function of Neuronal Nicotinic Acetylcholine Receptor Inhibitors Derived From Natural Toxins
TN Ho, N Abraham, RJ Lewis |
Frontiers in neuroscience | 2020 |
|
‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab
J Vissing, S Jacob, KP Fujita, F OBrien, JF Howard |
Journal of Neurology | 2020 |
|
Acute Myasthenia Crisis: A Critical Emergency Department Differential
CD Hogan, J Lee, BC Sleigh, PR Banerjee, L Ganti |
Cureus | 2020 |
|
Association of polycythemia vera with positive JAK2V617F mutation and myasthenia gravis: A report of two cases
S Sasi, MA Yassin, S Kamran, V Mnatsakanyan |
Clinical Case Reports | 2020 |
|
Identification of the Regulatory Role of lncRNA SNHG16 in Myasthenia Gravis by Constructing a Competing Endogenous RNA Network
J Wang, Y Cao, X Lu, X Wang, X Kong, C Bo, S Li, M Bai, Y Jiao, H Gao, X Yao, S Ning, L Wang, H Zhang |
Molecular Therapy — Nucleic Acids | 2020 |
|
Consistent improvement with eculizumab across muscle groups in myasthenia gravis
R Mantegazza, FL O'Brien, M Yountz, JF Howard, CG Mazia, M Wilken, F Barroso, J Saba, M Rugiero, M Bettini, M Chaves, G Vidal, AD Garcia, JD Bleecker, GV den Abeele, K de Koning, KD Mey, R Mercelis, D Mahieu, L Wagemaekers, PV Damme, A Depreitere, C Schotte, C Smetcoren, O Stevens, SV Daele, N Vandenbussche, A Vanhee, S Verjans, J Vynckier, A DHont, P Tilkin, AA de Siqueira Carvalho, ID Brockhausen, D Feder, D Ambrosio, P César, AP Melo, RM Ribeiro, R Rocha, BB Rosa, T Veiga, LA da Silva, MS Engel, JG Geraldo, M da Penha Ananias Morita, EN Coelho, G Paiva, M Pozo, N Prando, DD Torres, CF Butinhao, G Duran, TA Fialho, TC da Silva, LO Gonçalves, LE Pazetto, LR Volpe, LS Duca, MA Friedrich, A Guerreiro, H Mohr, MP Martins, D da Cruz Pacheco, L Ferreira, AP Macagnan, G Pinto, A de Cassia Santos, AS Oliveira, AC de Andrade, M Annes, LD Silva, VC Lino, W Pinto, N Assis, F Carrara, C Miranda, I Souza, P Fernandes, Z Siddiqi, C Phan, J Narayan, D Blackmore, A Mallon, R Roderus, E Watt, S Vohanka, J Bednarik, M Chmelikova, M Cierny, S Toncrova, J Junkerova, B Kurkova, K Reguliova, O Zapletalova, J Pitha, I Novakova, M Tyblova, I Jurajdova, M Wolfova, H Andersen, T Harbo, L Vinge, S Krogh, A Mogensen, J Vissing, J Højgaard, N Witting, AM Autzen, J Pedersen, JP Erälinna, M Laaksonen, O Oksaranta, T Harrison, J Eriksson, C Rozsa, M Horvath, G Lovas, J Matolcsi, G Szabo, G Jakab, B Szabadosne, L Vecsei, L Dezsi, E Varga, M Konyane, G Antonini, AD Pasquale, M Garibaldi, S Morino, F Troili, L Fionda, A Pasquale, A Evoli, PE Alboini, V DAmato, R Iorio, M Inghilleri, L Fionda, V Frasca, E Giacomelli, M Gori, D Lopergolo, E Onesti, V Frasca, M Gabriele, F Saccà, A Filla, T Costabile, E Marano, A Fasanaro, A Marsili, G Puorro, C Antozzi, S Bonanno, G Camera, A Locatelli, L Maggi, M Pasanisi, A Campanella, A Uzawa, T Kanai, N Kawaguchi, M Mori, Y Kaneko, A Kanzaki, E Kobayashi, H Murai, K Masaki, D Matsuse, T Matsushita, T Uehara, M Shimpo, M Jingu, K Kikutake, Y Nakamura, Y Sano, K Utsugisawa, Y Nagane, I Kamegamori, T Tsuda, Y Fujii, K Futono, Y Ozawa, A Mizugami, Y Saito, M Samukawa, H Suzuki, M Morikawa, S Kamakura, E Miyawaki, M Okumura, S Funaka, T Kawamura, M Nakamori, M Takahashi, N Taichi, T Hasuike, E Higuchi, H Kobayashi, K Osakada, H Shiraishi, T Miyazaki, M Motomura, A Mukaino, S Yoshimura, S Asada, S Yoshida, S Amamoto, T Kobashikawa, M Koga, Y Maeda, K Takada, M Takada, M Tsurumaru, Y Yamashita, Y Suzuki, T Akiyama, K Narikawa, O Tano, K Tsukita, R Kurihara, F Meguro, Y Fukuda, M Sato, T Imai, E Tsuda, S Shimohama, T Hayashi, S Hisahara, T Imai, J Kawamata, T Murahara, M Saitoh, S Shimohama, S Suzuki, D Yamamoto, Y Ishiyama, N Ishiyama, M Noshiro, R Takeyama, K Uwasa, I Yasuda, A van der Kooi, M de Visser, T Gibson, BJ Kim, CN Lee, YS Koo, HY Seok, HN Kang, HJ Ra, BJ Kim, EB Cho, MS Choi, HL Lee, JH Min, J Seok, JE Lee, DY Koh, JY Kwon, SA Park, EH Choi, YH Hong, SH Ahn, DL Koo, JS Lim, CW Shin, JY Hwang, M Kim, SM Kim, HN Jeong, JW Jung, Y Kim, HS Lee, HY Shin, EB Hwang, M Shin, C Casasnovas, MA Aguilo, C HomedesPedret, NJ Palacios, LD Porras, VV Santamaria, A Lazaro, JG Carbonell, P Sune, MS Figueras, G Gili, G Mazuela, I Illa, EC Vicente, J DiazManera, LA Gutiérrez, RR Garcia, N Vidal, E ArribasIbar, ED Tejedor, PG Salcedo, M FernandezFournier, PL Ruiz, FJ de Rivera, M FernandezFournier, M Sastre, F Piehl, A Hietala, L Bjarbo, I Sengun, A Meherremova, P Ozcelik, B Balkan, C Tuga, M Ugur, S ErdemOzdamar, CE BekircanKurt, NP Acar, E Yilmaz, Y Caliskan, G Orsel, H Efendi, S Aydinlik, H Cavus, A Kutlu, G Becerikli, C Semiz, O Tun, M Terzi, B Dogan, MK Onar, S Sen, TK Cavdar, A Veske, F Norwood, A Dimitriou, J Gollogly, M MahdiRogers, A Seddigh, G Sokratous, G Maier, F Sohail, S Jacob, G Sadalage, P Torane, C Brown, A Shah, S Sathasivam, H Arndt, D Davies, D Watling, A Amato, T Cochrane, M Salajegheh, K Roe, K Amato, S Toska, G Wolfe, N Silvestri, K Patrick, K Zakalik, J Katz, R Miller, M Engel, D Forshew, E Bravver, B Brooks, M Sanjak, S Plevka, M Burdette, S Cunningham, M Kramer, J Nemeth, C Schommer, T Scott, V Juel, J Guptill, L HobsonWebb, J Massey, K Beck, D Carnes, J Loor, A Anderson, R Pascuzzi, C Bodkin, J Kincaid, R Snook, S Guingrich, A Micheels, V Chaudhry, A Corse, B Mosmiller, A Kelley, D Ho, J Srinivasan, M Vytopil, J Jara, N Ventura, C Carter, C Donahue, C Herbert, S Scala, E Weiner, S Alam, J McKinnon, L Haar, N McKinnon, K Alcon, K McKenna, N Sattar, K Daniels, D Jeffery, M Freimer, JC Hoyle, J Kissel, J Agriesti, S Chelnick, L Mezache, C Pineda, F Muharrem, C Karam, J Khoury, T Marburger, H Kaur, D Dimitrova, J Gilchrist, B Agrawal, M Elsayed, S Kohlrus, A Ardoin, T Darnell, L Golden, B Lokaitis, J Seelbach, S Muppidi, N Goyal, S Sakamuri, YT So, S Paulose, S Pol, L Welsh, R BhavarajuSanka, AT Gonzalez, L Dishman, F Jones, A Gonzalez, P Padilla, A Saklad, M Silva, S Nations, J Trivedi, S Hopkins, M Kazamel, M Alsharabati, L Lu, K Nozaki, S MumfreyThomas, A Woodall, T Mozaffar, T Cash, N Goyal, G Roy, V Mathew, F Maqsood, B Minton, HJ Jones, J Rosenfeld, R Garcia, L Echevarria, S Garcia, M Pulley, S Aranke, AR Berger, J Shah, Y Shabbir, L Smith, M Varghese, Y Shabbir, L Gutmann, L Gutmann, N Jerath, C Nance, A Swenson, H Olalde, N Kressin, J Sieren, R Barohn, M Dimachkie, M Glenn, A McVey, M Pasnoor, J Statland, Y Wang, T Liu, K Emmons, N Jenci, J Locheke, A Fondaw, K Johns, G Rico, M Walsh, L Herbelin, C HaferMacko, J Kwan, L Zilliox, K Callison, V Young, B DiSanzo, K Naunton, M Benatar, M Bilsker, K Sharma, A Cooley, E Reyes, SC Michon, D Sheldon, J Steele, C Karam, R Traub, M Chopra, T Vu, L Katzin, T McClain, B Harvey, A Hart, K Huynh, S Beydoun, A Chilingaryan, V Doan, B Droker, H Gong, S Karimi, F Lin, T McClain, K Polaka, A Shah, A Tran, S Akhter, A Malekniazi, R Tandan, M Hehir, W Waheed, S Lucy, M Weiss, J Distad, S Strom, S Downing, B Kim, T Bertorini, T Arnold, K Henderson, R Pillai, Y Liu, L Wheeler, J Hewlett, M Vanderhook, R Nowak, D Dicapua, B Keung, A Kumar, H Patwa, K Robeson, I Yang, J Nye, H Vu |
Annals of Clinical and Translational Neurology | 2020 |
|
Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis
JS Yi, MA Russo, S Raja, JM Massey, VC Juel, J Shin, LD Hobson-Webb, K Gable, JT Guptill |
Experimental Neurology | 2020 |
|
Clinical features of LRP4 /agrin‐antibody–positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu, JF Howard, A Corse, MM Dimachkie, C Jackson, T Vu, G Small, RP Lisak, J Belsh, I Lee, RJ Nowak, V Baute, S Scelsa, JA Fernandes, Z Simmons, A Swenson, R Barohn, RB Sanka, C Gooch, E Ubogu, J Caress, M Pasnoor, H Xu, L Mei |
Muscle & Nerve | 2020 |
|
Review Analysis on Thymectomy vs Conservative Medical Management in Myasthenia Gravis
Rashid MH, Yasir HK, Piracha MU, Salman U, Yousaf H |
Cureus | 2020 |
|
Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study
Nowak RJ, Muppidi S, Beydoun SR, O'Brien FL, Yountz M, Howard JF Jr |
Frontiers in neurology | 2020 |
|
History of Myasthenia Gravis Revisited
Deymeer F |
2020 | |
|
The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
L Antonioli, C Blandizzi, P Pacher, G Haskó, C Page |
Pharmacological reviews | 2019 |
|
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review
JL Chamberlain, S Huda, DH Whittam, M Matiello, BP Morgan, A Jacob |
Journal of Neurology | 2019 |
|
Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) for targeted antibody blocking
L Zhang, H Shen, Y Gong, X Pang, M Yi, L Guo, J Li, S Arroyo, X Lu, S Ovchinnikov, G Cheng, X Liu, X Jiang, S Feng, H Deng |
Chemical Science | 2019 |
|
Immunosuppressive and monoclonal antibody treatment for myasthenia gravis: A network meta-analysis
L Wang, X Huan, , H Wu, L Zhou, JH Lu, TS Zhang, CB Zhao |
CNS Neuroscience & Therapeutics | 2019 |
|
The ancient sarcomeric myosins found in specialized muscles
LA Lee, A Karabina, LJ Broadwell, LA Leinwand |
Skeletal Muscle | 2019 |
|
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis: Long-Term Eculizumab in gMG
S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, J Vissing, TM Burns, JT Kissel, RJ Nowak, H Andersen, C Casasnovas, JL de Bleecker, TH Vu, R Mantegazza, FL O'Brien, JJ Wang, KP Fujita, JF Howard |
Muscle & Nerve | 2019 |
|
Eculizumab improves fatigue in refractory generalized myasthenia gravis
H Andersen, R Mantegazza, JJ Wang, F OBrien, K Patra, JF Howard |
Quality of Life Research | 2019 |
|
Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life:
AN Boscoe, H Xin, GJ LʼItalien, LA Harris, GR Cutter |
Journal of Clinical Neuromuscular Disease | 2019 |
|
Examining the Impact of Refractory Myasthenia Gravis on Healthcare Resource Utilization in the United States: Analysis of a Myasthenia Gravis Foundation of America Patient Registry Sample
H Xin, LA Harris, IB Aban, G Cutter |
Journal of clinical neurology (Seoul, Korea) | 2019 |
|
Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study
Virameteekul S, Charoensri S, Sawanyawisuth K, Tiamkao S |
2019 | |
|
Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis: Engineered Agrin Attenuates EAMG
Z Li, M Li, K Wood, S Hettwer, SA Muley, FD Shi, Q Liu, SS Ladha |
Muscle & Nerve | 2018 |
|
Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission
M Morsch, DA Protti, D Cheng, F Braet, RS Chung, SW Reddel, WD Phillips |
Scientific Reports | 2018 |
|
When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
R Mantegazza, C Antozzi |
Therapeutic advances in neurological disorders | 2018 |
|
Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
C Galdeano, N Coquelle, M Cieslikiewicz-Bouet, M Bartolini, B Pérez, M Clos, I Silman, L Jean, JP Colletier, PY Renard, D Muñoz-Torrero |
Molecules (Basel, Switzerland) | 2018 |
|
Advances in autoimmune myasthenia gravis management
S Wang, I Breskovska, S Gandhy, AR Punga, JT Guptill, HJ Kaminski |
Expert Review of Neurotherapeutics | 2018 |
|
Thymectomy in nonthymomatous myasthenia gravis - systematic review and meta-analysis
AJ Cataneo, G Felisberto, DC Cataneo |
Orphanet Journal of Rare Diseases | 2018 |
|
General anesthesia using supraglottic airway device in a myasthenic patient undergoing reverse shoulder arthroplasty
SS Kamath, JC Misquith |
Anesthesia: Essays and Researches | 2018 |
|
Unexpected dislocation following accurate total hip arthroplasty caused by excessive hip joint laxity during myasthenic crisis: a case report
Y Murotani, Y Kuroda, K Goto, T Kawai, S Matsuda |
Journal of medical case reports | 2018 |
|
Modified Buzhong Yiqi decoction for myasthenia gravis: A systematic review protocol
X Jiang, G Chen, J Huang, L Xie, D Shen, K Jiang, H Xu |
Medicine | 2018 |
|
Mechanisms of Autoantibody-Induced Pathology
RJ Ludwig, K Vanhoorelbeke, F Leypoldt, Z Kaya, K Bieber, SM McLachlan, L Komorowski, J Luo, O Cabral-Marques, CM Hammers, JM Lindstrom, P Lamprecht, A Fischer, G Riemekasten, C Tersteeg, P Sondermann, B Rapoport, KP Wandinger, C Probst, AE Beidaq, E Schmidt, A Verkman, RA Manz, F Nimmerjahn |
Frontiers in immunology | 2017 |
|
Autoimmune Thyroiditis and Myasthenia Gravis
A Lopomo, S Berrih-Aknin |
Frontiers in Endocrinology | 2017 |
|
Response to: Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
Y Cao, J Wang, H Zhang, Q Tian, L Chen, S Ning, P Liu, X Sun, X Lu, C Song, S Zhang, B Xiao, L Wang |
BioMed Research International | 2017 |
|
Suppression of CHRN endocytosis by carbonic anhydrase CAR3 in the pathogenesis of myasthenia gravis
A Du, S Huang, X Zhao, K Feng, S Zhang, J Huang, X Miao, F Baggi, RS Ostrom, Y Zhang, X Chen, C Xu |
Autophagy | 2017 |
|
The potential role of cell surface complement regulators and circulating CD4+ CD25+ T-cells in the development of autoimmune myasthenia gravis
MN Hamdoon, M Fattouh, AN El-din, HM Elnady |
Electronic Physician | 2016 |
|
Concomitant presentation of Anderson-Tawil syndrome and myasthenia gravis in an adult patient: A case report
R Fan, R Ji, W Zou, G Wang, H Wang, D Penney, J Luo, Y Fan |
Experimental and therapeutic medicine | 2016 |
|
Animal models of myasthenia gravis: utility and limitations
R Mantegazza, C Cordiglieri, A Consonni, F Baggi |
International journal of general medicine | 2016 |
|
Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft Rejection
YH Jeon, YS Choi |
Immune Network | 2016 |
|
Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy
JE Poort, MB Rheuben, SM Breedlove, CL Jordan |
Human Molecular Genetics | 2016 |
|
Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing
L Udrescu, L Sbârcea, A Topîrceanu, A Iovanovici, L Kurunczi, P Bogdan, M Udrescu |
Scientific Reports | 2016 |
|
Seropositivity for West Nile Virus Antibodies in Patients Affected by Myasthenia Gravis
M Greco, P Cofano, G Lobreglio |
Journal of clinical medicine research | 2016 |
|
Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis
JT Guptill, VC Juel, JM Massey, AC Anderson, M Chopra, JS Yi, E Esfandiari, T Buchanan, B Smith, P Atherfold, E Jones, JF Howard |
Autoimmunity | 2016 |
|
Double Seronegative Myasthenia Gravis with Anti-LRP4 Antibodies Presenting with Dropped Head and Acute Respiratory Insufficiency
G Beck, T Yabumoto, K Baba, T Sasaki, O Higuchi, H Matsuo, H Mochizuki |
Internal Medicine | 2016 |
|
A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells
M Homma, A Uzawa, H Tanaka, N Kawaguchi, T Kanai, K Nakajima, M Narita, Y Hara, H Maruyama, Y Ogawa, K Himuro, S Kuwabara |
Neurotherapeutics | 2016 |
|
Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis
G Citirak, S Cejvanovic, H Andersen, J Vissing, AV Gomes |
PloS one | 2016 |
|
Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab
Sreenivasa Rao Sudulagunta, Mona Sepehrar, Mahesh Babu Sodalagunta, Aravinda Settikere Nataraju, Shiva Kumar Bangalore Raja, Deepak Sathyanarayana, Siddharth Gummadi, Hemanth Kumar Burra |
GMS German Medical Science | 2016 |
|
Animal Models for the Study of Neuroimmunological Disease
Croxford JL, Miyake S |
Neuroimmunological Diseases | 2016 |
|
Validation of the MG-DIS: a disability assessment for myasthenia gravis.
Raggi A, Leonardi M, Schiavolin S, Antozzi C, Brenna G, Maggi L, Mantegazza R |
Journal of Neurology | 2016 |
|
Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model—Recommendations for methods and experimental designs
LL Kusner, M Losen, A Vincent, J Lindstrom, S Tzartos, K Lazaridis, P Martinez-Martinez |
Experimental Neurology | 2015 |
|
Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients
S Nakane, O Higuchi, M Koga, T Kanda, K Murata, T Suzuki, H Kurono, M Kunimoto, K Kaida, A Mukaino, W Sakai, Y Maeda, H Matsuo, G Saruhan-Direskeneli |
PloS one | 2015 |
|
Deficits in Endogenous Adenosine Formation by Ecto-5′-Nucleotidase/CD73 Impair Neuromuscular Transmission and Immune Competence in Experimental Autoimmune Myasthenia Gravis
L Oliveira, A Correia, AC Costa, S Guerra-Gomes, F Ferreirinha, MT Magalhães-Cardoso, M Vilanova, P Correia-de-Sá |
Mediators of Inflammation | 2015 |
|
Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis
Y Cao, J Wang, H Zhang, Q Tian, L Chen, S Ning, P Liu, X Sun, X Lu, C Song, S Zhang, B Xiao, L Wang |
BioMed Research International | 2015 |
|
A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis
DB Sanders, J Rosenfeld, MM Dimachkie, L Meng, FI Malik |
Neurotherapeutics | 2015 |
|
A Challenging Diagnosis of Fluctuating Dyspnea: Myasthenia Gravis
R Mandaliya |
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH | 2015 |
|
Paravertebral Block Combined with Sedation for a Myasthenic Patient Undergoing Breast Augmentation
B Kozanhan, B Basaran, L Kutlucan, S Ozmen |
Case Reports in Anesthesiology | 2015 |
|
Myeloid-Derived Suppressor Cells as a Potential Therapy for Experimental Autoimmune Myasthenia Gravis
Y Li, Z Tu, S Qian, JJ Fung, SD Markowitz, LL Kusner, HJ Kaminski, L Lu, F Lin |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
|
Targeting therapy to the neuromuscular junction: Proof of concept: Targeted Therapy for MG
LL Kusner, N Satija, G Cheng, HJ Kaminski |
Muscle & Nerve | 2014 |
|
RNA Expression Analysis of Passive Transfer Myasthenia Supports Extraocular Muscle as a Unique Immunological Environment
Y Zhou, HJ Kaminski, B Gong, G Cheng, JM Feuerman, L Kusner |
Investigative ophthalmology & visual science | 2014 |
|
Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis
N Ghazanfari, M Morsch, N Tse, SW Reddel, WD Phillips |
PloS one | 2014 |
|
Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis
S George, S Paulick, I Knütter, N Röber, R Hiemann, D Roggenbuck, K Conrad, JH Küpper |
PloS one | 2014 |
|
Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis
M Thiruppathi, JR Sheng, L Li, BS Prabhakar, MN Meriggioli |
Journal of Autoimmunity | 2014 |
|
Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients
G Nogales-Gadea, A Ramos-Fransi, X Suárez-Calvet, M Navas, R Rojas-García, JL Mosquera, J Díaz-Manera, L Querol, E Gallardo, I Illa |
PloS one | 2014 |
|
Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report
D Dan, PA Bart, J Novy, T Kuntzer, C Clair |
Journal of medical case reports | 2014 |
|
Localized Thymic Amyloidosis Presenting with Myasthenia Gravis: Case Report
SM Son, YM Lee, SW Kim, OJ Lee |
Journal of Korean Medical Science | 2014 |
|
Whole-Genome Analysis in Korean Patients with Autoimmune Myasthenia Gravis
SJ Na, JH Lee, SW Kim, DS Kim, EH Shon, HJ Park, HY Shin, SM Kim, YC Choi |
Yonsei Medical Journal | 2014 |
|
Neuromodulation by acetylcholine: examples from schizophrenia and depression
MJ Higley, MR Picciotto |
Current Opinion in Neurobiology | 2014 |
|
Myasthenia gravis-like syndrome presenting as a component of the paraneoplastic syndrome of lung adenocarcinoma in a nonsmoker
S Eivaz-Mohammadi, F Gonzalez-Ibarra, H Hekmatjou, R Mikkilineni, A Patel, AK Syed |
Case Reports in Oncological Medicine | 2014 |
|
Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study
LL Kusner, MJ Ciesielski, A Marx, HJ Kaminski, RA Fenstermaker |
PloS one | 2014 |
|
Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
J Kerr, I Quinti, M Eibl, H Chapel, PJ Späth, WA Sewell, A Salama, IN van Schaik, TW Kuijpers, HH Peter |
Frontiers in immunology | 2014 |
|
Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis: IVIg therapy in myasthenia gravis
J Gamez |
Clinical & Experimental Immunology | 2014 |
|
Tirasemtiv amplifies skeletal muscle response to nerve activation in humans: Tirasemtiv in Humans
R Hansen, KG Saikali, W Chou, AJ Russell, MM Chen, V Vijayakumar, RR Stoltz, S Baudry, RM Enoka, DJ Morgans, AA Wolff, FI Malik |
Muscle & Nerve | 2014 |
|
Ocular myasthenia gravis: A review
P Patil-Chhablani, DV Venkatramani, RA Gandhi, AG Nair |
Indian journal of ophthalmology | 2014 |
|
Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
G Kordas, G Lagoumintzis, S Sideris, K Poulas, SJ Tzartos, W Phillips |
PloS one | 2014 |
|
DBC1 Is a Suppressor of B Cell Activation by Negatively Regulating Alternative NF- B Transcriptional Activity
S Kong, M Thiruppathi, Q Qiu, Z Lin, H Dong, EN Chini, BS Prabhakar, D Fang |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
|
Antigen-Specific Immunotherapeutic Vaccine for Experimental Autoimmune Myasthenia Gravis
J Luo, J Lindstrom |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
|
Acetylcholinesterase inhibitor treatment for myasthenia gravis
Mehndiratta MM, Pandey S, Kuntzer T |
The Cochrane Database of Systematic Reviews | 2014 |
|
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays
A Becker, N Ludwig, A Keller, B Tackenberg, C Eienbröker, WH Oertel, K Fassbender, E Meese, K Ruprecht |
PloS one | 2013 |
|
Induced Formation and Maturation of Acetylcholine Receptor Clusters in a Defined 3D Bio-Artificial Muscle
L Wang, J Shansky, H Vandenburgh |
Molecular Neurobiology | 2013 |
|
Improved methodology to obtain large quantities of correctly folded recombinant N-terminal extracellular domain of the human muscle acetylcholine receptor for inducing experimental autoimmune myasthenia gravis in rats
C Sun, H Zhang, J Xu, J Gao, X Qi, Z Li |
Archives of Medical Science : AMS | 2013 |
|
Pyridostigmine-induced high grade SA-block in a patient with myasthenia gravis
S Said, CJ Cooper, H Alkhateeb, S Elhanafi, J Bizet, S Gosavi, Z Abedin |
American Journal of Case Reports | 2013 |
|
Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina
OW Gramlich, S Beck, NT Hohenstein-Blaul, N Boehm, A Ziegler, JM Vetter, N Pfeiffer, FH Grus |
PloS one | 2013 |
|
Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis.
Li Y, Rauniyar VK, Yin WF, Hu B, Ouyang S, Xiao B, Yang H |
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2013 |
|
Environmental effects of anticholinesterasic therapeutic drugs on a crustacean species, Daphnia magna.
Rocha R, Gonçalves F, Marques C, Nunes B |
Environmental Science and Pollution Research | 2013 |
|
A Comparison of Epitope Repertoires Associated with Myasthenia Gravis in Humans and Nonhuman Hosts
K Vaughan, Y Kim, A Sette |
Autoimmune Diseases | 2012 |
|
Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases
AJ Russell, JJ Hartman, AC Hinken, AR Muci, R Kawas, L Driscoll, G Godinez, KH Lee, D Marquez, WF 4th, MM Chen, D Clarke, SE Collibee, M Garard, R Hansen, Z Jia, PP Lu, H Rodriguez, KG Saikali, J Schaletzky, V Vijayakumar, DL Albertus, DR Claflin, DJ Morgans, BP Morgan, FI Malik |
Nature Medicine | 2012 |
|
Fracture rate in patients with myasthenia gravis: the general practice research database
S Pouwels, A Boer, MK Javaid, D Hilton-Jones, J Verschuuren, C Cooper, HG Leufkens, F Vries |
Osteoporosis International | 2012 |
|
An undiagnosed myasthenia gravis presenting as isolated recurrent acute respiratory failure
SR Sharma, N Sharma, M Yeolekar |
Journal of Neurosciences in Rural Practice | 2012 |
|
Possible Involvement of Toll-Like Receptors in the Pathogenesis of Myasthenia Gravis
YZ Wang, M Yan, FF Tian, JM Zhang, Q Liu, H Yang, WB Zhou, J Li |
Inflammation | 2012 |
|
Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis
CS Chae, HK Kwon, JS Hwang, JE Kim, SH Im |
PloS one | 2012 |
|
Biomarker development for myasthenia gravis
HJ Kaminski, LL Kusner, GI Wolfe, I Aban, G Minisman, R Conwit, G Cutter |
Annals of the New York Academy of Sciences | 2012 |
|
Myasthenia gravis: a review
AJ Trouth, A Dabi, N Solieman, M Kurukumbi, J Kalyanam |
Autoimmune Diseases | 2012 |
|
Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis
J Soltys, X Wu |
Journal of Inflammation | 2012 |
|
Chromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controls
JA Bailey, DK Lahiri |
Journal of Neurochemistry | 2012 |
|
Evaluation of a scale of patient-reported outcomes for the assessment of myasthenia gravis patients in China.
Liu FB, Chen XL, Guo L, Liu XB |
Chinese Journal of Integrative Medicine | 2012 |
|
Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.
Cetin H, Fülöp G, Zach H, Auff E, Zimprich F |
Wiener klinische Wochenschrift | 2012 |
|
Treatment for diplopia in patients with myasthenia gravis.
Park KA, Oh SY |
2012 | |
|
A case of Sheehan's syndrome that manifested as bilateral ptosis
YS Lee, SS Moon |
Journal of Korean Medical Science | 2011 |
|
Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis
HS Roh, SY Lee, JS Yoon |
Korean journal of ophthalmology : KJO | 2011 |
|
Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors
J Luo, J Lindstrom |
Autoimmunity | 2011 |
|
Myasthenia Gravis: A Review of Available Treatment Approaches
NE Gilhus, JF Owe, JM Hoff, F Romi, GO Skeie, JA Aarli |
Autoimmune Diseases | 2011 |
|
The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature
M Jallouli, D Saadoun, B Eymard, G Leroux, J Haroche, DT Huong, C Gennes, C Chapelon, O Benveniste, B Wechsler, P Cacoub, Z Amoura, JC Piette, N Costedoat-Chalumeau |
Journal of Neurology | 2011 |
|
Molecular control of neuromuscular junction development
E Ferraro, F Molinari, L Berghella |
Journal of Cachexia, Sarcopenia and Muscle | 2011 |
|
Anaesthetic management of a patient with myasthenia gravis for abdominal surgery using sugammadex
A Rudzka-Nowak, M Piechota |
Archives of Medical Science : AMS | 2011 |
|
Response of patients with refractory myasthenia gravis to rituximab: a retrospective study
RJ Nowak, DB Dicapua, N Zebardast, JM Goldstein |
Therapeutic advances in neurological disorders | 2011 |
|
Treatment of myasthenia gravis.
Kumar V, Kaminski HJ |
Current Neurology and Neuroscience Reports | 2011 |
|
Thymectomy for inducing remission in juvenile myasthenia gravis.
Hennessey IA, Long AM, Hughes I, Humphrey G |
Pediatric Surgery International | 2011 |
|
Elevated serum level of interleukin-32α in the patients with myasthenia gravis.
Na SJ, So SH, Lee KO, Choi YC |
Journal of Neurology | 2011 |
|
A retrospective review of 15 patients with familial myasthenia gravis over a period of 25 years.
Feng HY, Liu WB, Luo CM, Yang LX, Fang W, Qiu L, Huang X, Li Y, Huang RX |
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2011 |
|
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
EG Hughes, X Peng, AJ Gleichman, M Lai, L Zhou, R Tsou, TD Parsons, DR Lynch, J Dalmau, RJ Balice-Gordon |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2010 |
|
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
A Sesarman, G Vidarsson, C Sitaru |
Cellular and Molecular Life Sciences | 2010 |
|
Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice: Actions of MuSK autoantibodies in experimental myasthenia gravis
RN Cole, N Ghazanfari, ST Ngo, OL Gervásio, SW Reddel, WD Phillips |
The Journal of Physiology | 2010 |
|
Sorting receptor Rer1 controls surface expression of muscle acetylcholine receptors by ER retention of unassembled alpha-subunits
C Valkova, M Albrizio, IV Röder, M Schwake, R Betto, R Rudolf, C Kaether |
Proceedings of the National Academy of Sciences | 2010 |
|
Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine
QS Yu, HW Holloway, W Luo, DK Lahiri, A Brossi, NH Greig |
Bioorganic & Medicinal Chemistry | 2010 |
|
Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis
M Blaha, J Pit'ha, V Blaha, M Lanska, J Maly, S Filip, H Langrova |
Journal of biomedicine & biotechnology | 2010 |
|
Myasthenia gravis presenting as isolated respiratory failure: a case report
WH Kim, JH Kim, EK Kim, SP Yun, KK Kim, WC Kim, HC Jeong |
The Korean Journal of Internal Medicine | 2010 |
|
Social support and self-efficacy in patients with Myasthenia Gravis: a common pathway towards positive health outcomes.
Raggi A, Leonardi M, Mantegazza R, Casale S, Fioravanti G |
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2010 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
Acetylcholine receptor-α subunit expression in myasthenia gravis: A role for the autoantigen in pathogenesis?
JR Sheng, LC Li, BS Prabhakar, MN Meriggioli |
Muscle & Nerve | 2009 |
|
Novel complement inhibitor limits severity of experimentally myasthenia gravis
J Soltys, LL Kusner, A Young, C Richmonds, D Hatala, B Gong, V Shanmugavel, HJ Kaminski |
Annals of Neurology | 2009 |
|
Specific immunotherapy of experimental myasthenia gravis by a novel mechanism
J Luo, A Kuryatov, JM Lindstrom |
Annals of Neurology | 2009 |
|
Novel information on the non-neuronal cholinergic system in orthopedics provides new possible treatment strategies for inflammatory and degenerative diseases
S Forsgren, H Alfredson, D Bjur, S Rantapää-Dahlqvist, O Norrgård, T Dalén, P Danielson |
Orthopedic reviews | 2009 |
|
Antigenic structure of the human muscle nicotinic acetylcholine receptor main immunogenic region
J Luo, J Lindstrom |
Journal of molecular neuroscience : MN | 2009 |
|
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
M Gurevich, T Tuller, U Rubinstein, R Or-Bach, A Achiron |
BMC Medical Genomics | 2009 |
|
An Altered Phenotype in a Conditional Knockout of Pitx2 in Extraocular Muscle
Y Zhou, G Cheng, L Dieter, TA Hjalt, FH Andrade, JS Stahl, HJ Kaminski |
Investigative ophthalmology & visual science | 2009 |
|
The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study.
Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R |
Journal of Neurology | 2009 |
|
Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis.
Raggi A, Leonardi M, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R |
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2009 |
|
Extraocular Muscle Susceptibility to Myasthenia Gravis
J Soltys, B Gong, HJ Kaminski, Y Zhou, LL Kusner |
Annals of the New York Academy of Sciences | 2008 |
|
Effect of complement and its regulation on myasthenia gravis pathogenesis
LL Kusner, HJ Kaminski, J Soltys |
Expert Review of Clinical Immunology | 2008 |
|
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn
AR Mezo, KA McDonnell, CA Hehir, SC Low, VJ Palombella, JM Stattel, GD Kamphaus, C Fraley, Y Zhang, JA Dumont, AJ Bitonti |
Proceedings of the National Academy of Sciences | 2008 |
|
Autoantibodies in neuromuscular transmission disorders
A Vincent |
Annals of Indian Academy of Neurology | 2008 |
|
Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?
RA Wilson, JA Langermans, GJ van Dam, RA Vervenne, SL Hall, WC Borges, GP Dillon, AW Thomas, PS Coulson |
PLoS neglected tropical diseases | 2008 |
|
Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays
L Soreq, A Gilboa-Geffen, S Berrih-Aknin, P Lacoste, A Darvasi, E Soreq, H Bergman, H Soreq |
PloS one | 2008 |
|
Myasthenia gravis in a patient affected by glycogen storage disease type Ib: A further manifestation of an increased risk for autoimmune disorders?
D Melis, F Balivo, RD Casa, A Romano, R Taurisano, B Capaldo, G Riccardi, MR Monsurrò, G Parenti, G Andria |
Journal of Inherited Metabolic Disease | 2008 |
|
Discrimination between Host and Pathogens by the Complement System
Pangburn MK, Ferreira VP, Cortes C |
Vaccine | 2008 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)